Small randomized trials

被引：18

作者：

Redman, Mary

Crowley, John

机构：

[1] Fred Hutchinson Canc Res Ctr, SW Oncol Grp, Ctr Stat, Seattle, WA 98109 USA

[2] CRAB, Seattle, WA USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2007年 / 2卷 / 01期

关键词：

LUNG-CANCER; DESIGN;

D O I：

10.1097/JTO.0b013e31802c8d84

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1 / 2

页数：2

共 6 条

[1] Standard versus dose-intensified chemotherapy with sequential reinfusion of hematopoietic progenitor cells in small cell lung cancer patients with favorable prognosis [J].

Buchholz, Erika ;

Manegold, Christian ;

Pilz, Lothar ;

Thatcher, Nick ;

Drings, Peter .

JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (01) :51-58

[2]

Burdett S, 2006, J THORAC ONCOL, V1, P611

[3] Progression-free survival rate as primary end point for phase II cancer clinical trials: Application to mesothelioma - The EORTC Lung Cancer Group [J].

Francart, Julie ;

Legrand, Catherine ;

Sylvester, Richard ;

Van Glabbeke, Martine ;

van Meerbeeck, Jan P. ;

Robert, Annie .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (19) :3007-3012

[4] Phase II clinical trial design: Methods in translational research from the Genitourinary Committee at the Eastern Cooperative Oncology Group [J].

Gray, R ;

Manola, J ;

Saxman, S ;

Wright, J ;

Dutcher, J ;

Atkins, M ;

Carducci, M ;

See, W ;

Sweeney, C ;

Liu, G ;

Stein, M ;

Dreicer, R ;

Wilding, G ;

DiPaola, RS .

CLINICAL CANCER RESEARCH, 2006, 12 (07) :1966-1969

[5]

Liu PY, 2006, HDB STAT CLIN ONCOLO, P155

[6] Design issues of randomized phase II trials and a proposal for phase II screening trials [J].

Rubinstein, LV ;

Korn, EL ;

Freidlin, B ;

Hunsberger, S ;

Ivy, SP ;

Smith, MA .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (28) :7199-7206

← 1 →